Cargando…

Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer's Disease

Inflammatory mediators are closely associated with the pathogenesis of neurodegenerative changes in Alzheimer's disease (AD) and mild cognitive impairment (MCI). Osteopontin (OPN) is a proinflammatory cytokine that has been shown to play an important role in various neuroinflammatory diseases....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yuan, Yin, Xue Song, Guo, Hong, Han, Rong Kun, He, Rui Dong, Chi, Li Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612435/ https://www.ncbi.nlm.nih.gov/pubmed/23576854 http://dx.doi.org/10.1155/2013/615745

Ejemplares similares

Verbal Episodic Memory and Endogenous Estradiol: An Association in Patients with Mild Cognitive Impairment and Alzheimer's Disease
por: Bittner, D. M., et al.
Publicado: (2011)

A Two-Study Comparison of Clinical and MRI Markers of Transition from Mild Cognitive Impairment to Alzheimer's Disease
por: Devanand, D. P., et al.
Publicado: (2012)

Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
por: Leroi, Iracema, et al.
Publicado: (2012)

Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
por: Chai, Yuek Ling, et al.
Publicado: (2021)

Movements Execution in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
por: Camarda, Rosolino, et al.
Publicado: (2007)

Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer's and Cognitively Normal Elderly
por: Hall, James R., et al.
Publicado: (2011)

Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer’s disease
por: Zhao, Aonan, et al.
Publicado: (2022)

KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients
por: Malek-Ahmadi, Michael, et al.
Publicado: (2013)

Elevated Angiopoietin-1 Serum Levels in Patients with Alzheimer's Disease
por: Schreitmüller, Brigitte, et al.
Publicado: (2012)

Mild Cognitive Impairment: Statistical Models of Transition Using Longitudinal Clinical Data
por: Abner, Erin L., et al.
Publicado: (2012)

U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study
por: Yang, Yuqi, et al.
Publicado: (2023)

Physical Performance Is Associated with Working Memory in Older People with Mild to Severe Cognitive Impairment
por: Volkers, K. M., et al.
Publicado: (2014)

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia
por: Spitzer, Philipp, et al.
Publicado: (2011)

Transcranial Magnetic Stimulation to Address Mild Cognitive Impairment in the Elderly: A Randomized Controlled Study
por: Drumond Marra, Hellen Livia, et al.
Publicado: (2015)

Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment
por: Cooper, Yonatan A., et al.
Publicado: (2018)

Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013)

Impact of cognitive reserve on the progression of mild cognitive impairment to Alzheimer's disease in Japan
por: Osone, Akira, et al.
Publicado: (2015)

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease
por: Jiang, Hong, et al.
Publicado: (2011)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
por: Hayashi, Atsuko, et al.
Publicado: (2015)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

Osteopontin and Osteoprotegerin as Potential Biomarkers in Abdominal Aortic Aneurysm before and after Treatment
por: Filis, Konstantinos, et al.
Publicado: (2014)

Mild cognitive impairment: an epidemiological perspective
por: Ritchie, Karen
Publicado: (2004)

A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease
por: Liu, Celina S., et al.
Publicado: (2020)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
por: Capucho, Patrícia Helena Figueirêdo Vale, et al.
Publicado: (2011)

Caspase-2 mRNA levels are not elevated in mild cognitive impairment, Alzheimer’s disease, Huntington’s disease, or Lewy Body dementia
por: Hlynialuk, Chris, et al.
Publicado: (2022)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

IDE Gene Polymorphism Influences on BPSD in Mild Dementia of Alzheimer's Type
por: Sato, Noriko, et al.
Publicado: (2008)

Osteopontin and Other Regulators of Angiogenesis and Fibrogenesis in the Vitreous from Patients with Proliferative Vitreoretinal Disorders
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2012)

The CC Genotype of Insulin-Induced Gene 2 rs7566605 Is a Protective Factor of Hypercholesteremia Susceptible to Mild Cognitive Impairment, Especially to the Executive Function of Patients with Type 2 Diabetes Mellitus
por: Zhang, Haoqiang, et al.
Publicado: (2020)

Abnormal Cortical Networks in Mild Cognitive Impairment and Alzheimer's Disease
por: Yao, Zhijun, et al.
Publicado: (2010)

The Self-Fulfilling Prophecy of Episodic Memory Impairment in Mild Cognitive Impairment: Do Episodic Memory Deficits Identified at Classification Remain Evident When Later Examined with Different Memory Tests?
por: Klekociuk, Shannon Zofia, et al.
Publicado: (2013)

Functional Cognitive Disorder and Mild Cognitive Impairment: A Thin Line
por: Jeje, Jide, et al.
Publicado: (2023)

Automatic morphometry in Alzheimer's disease and mild cognitive impairment()()
por: Heckemann, Rolf A., et al.
Publicado: (2011)

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
por: Chalermpalanupap, Termpanit, et al.
Publicado: (2013)

Anosognosia and Anosodiaphoria in Mild Cognitive Impairment and Alzheimer's Disease
por: Lindau, Maria, et al.
Publicado: (2014)

Prospective memory in Alzheimer’s disease and Mild Cognitive Impairment
por: Spíndola, Lívia, et al.
Publicado: (2011)

Assessment for apraxia in mild cognitive impairment and Alzheimer's dise
por: Ward, Mirela, et al.
Publicado: (2015)

Peripheral reaching in Alzheimer's disease and mild cognitive impairment
por: Mitchell, Alexandra G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ltn8g80h2pqnth03b4b2nqj3ki